Detecting drugs that cause thrombocytopenia: A comparison of published case reports and data mining of the USFDA adverse event reporting system (AERS) database.

被引:0
|
作者
Li, Xiaoning [1 ]
Terrell, Deirdra R. [1 ]
George, James N. [1 ]
Vesely, Sara K. [1 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
462
引用
收藏
页码:140A / 141A
页数:2
相关论文
共 50 条
  • [31] Venetoclax and Tumor Lysis Syndrome (TLS): Data Mining of the FDA Adverse Event Reporting System (FAERS) Database
    Giorgio, C. D.
    Pascale, G.
    Cimarusti, C. C.
    Corru, F.
    Drago, D.
    Napoli, L.
    Ingrilli, S.
    Ruggiero, F.
    Cervi, L.
    [J]. DRUG SAFETY, 2022, 45 (10) : 1155 - 1156
  • [32] Gabapentinoid abuse, suicide and behavior related adverse event reports: Data mining within FDA adverse events reporting system (FAERS)
    Elsobky, Yasmin
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2020, 105
  • [33] CRITICAL EVALUATION OF VARIOUS DATA MINING ALGORITHMS USED FOR SIGNAL DETECTION IN FDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Koonisetty, K. S.
    Subeesh, V
    Maheswari, E.
    Minnikanti, S. S.
    Pudi, C.
    [J]. VALUE IN HEALTH, 2018, 21 : S370 - S370
  • [34] Adverse drug events of denosumab: Data-mining based on the United States Food and Drug Administration Adverse Event Reporting System database
    Liu, Shaohua
    Jiang, Wangyan
    Guo, Jieru
    Zhou, Xinrong
    Liu, Zhelong
    [J]. JOURNAL OF RESEARCH IN PHARMACY, 2024, 28 (04): : 1220 - 1230
  • [35] Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports
    Wakao, Rika
    Taavola, Henric
    Sandberg, Lovisa
    Iwasa, Eiko
    Soejima, Saori
    Chandler, Rebecca
    Noren, G. Niklas
    [J]. DRUG SAFETY, 2019, 42 (12) : 1487 - 1498
  • [36] Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports
    Rika Wakao
    Henric Taavola
    Lovisa Sandberg
    Eiko Iwasa
    Saori Soejima
    Rebecca Chandler
    G. Niklas Norén
    [J]. Drug Safety, 2019, 42 : 1487 - 1498
  • [37] A post-marketing pharmacovigilance study of avapritinib: Adverse event data mining and analysis based on the United States Food and Drug Administration Adverse Event Reporting System database
    Rong, Li
    Xie, Mengyuan
    Jiang, Manxue
    Qiu, Hongyu
    Kong, Lingti
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (08) : 1816 - 1826
  • [38] A Real-World Pharmacovigilance Study of Ceftazidime/Avibactam: Data Mining of the Food and Drug Administration Adverse Event Reporting System Database
    Yao, Haiping
    Wang, Yanyan
    Peng, Yan
    Huang, Zhixiong
    Gan, Guoping
    Wang, Zhu
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (07): : 820 - 827
  • [39] Systematic analysis of safety profile for darunavir and its boosted agents using data mining in the FDA Adverse Event Reporting System database
    Tian, Xiaojiang
    Yao, Yao
    He, Guanglin
    Jia, Yuntao
    Wang, Kejing
    Chen, Lin
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [40] Systematic analysis of safety profile for darunavir and its boosted agents using data mining in the FDA Adverse Event Reporting System database
    Xiaojiang Tian
    Yao Yao
    Guanglin He
    Yuntao Jia
    Kejing Wang
    Lin Chen
    [J]. Scientific Reports, 11